Trials / Available
AvailableNCT03775187
Expanded Access to Burosumab
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options
Detailed description
Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Burosumab |
Timeline
- First posted
- 2018-12-13
- Last updated
- 2025-03-05
Source: ClinicalTrials.gov record NCT03775187. Inclusion in this directory is not an endorsement.